Please login to the form below

Not currently logged in
Email:
Password:

Former Tonic directors launch Iris Life Communications

Stéphanie Bunten and Lee-Ann Cameron's new agency will be based in London's Shoreditch
Iris Life Communications

Former Tonic Life Communications directors Stéphanie Bunten and Lee-Ann Cameron have joined forces to launch boutique health and wellness agency Iris Life Communications.

The new UK agency will cover international and domestic public relations, medical communications and consumer health PR, and aims to offer clients with a personalised approach to integrated communications.

Bunten, founder and managing director of Iris Life Communications and former Tonic managing director, commented: “We have a unique focus on the 'Science of Life', a fusion between the medical science of health and wellbeing, and the relationship science of interactions.

“Understanding both these elements provides us with a unique perspective to deliver engaging campaigns in this changing millennials to baby boomer healthcare landscape.”

Bunten's co-founder, and joint managing director, at the Shoreditch, London is Lee-Ann Cameron, was formerly an associate director at Tonic, before setting up Iris Life Communications after a short spell freelancing.

Cameron added: “With our 30-plus years of healthcare communications experience working across the spectrum of consumer health to big pharma, paired with our scientific backgrounds, we bring a high level of understanding, insight and creativity to communications initiatives.”

Article by
Kirstie Pickering

5th March 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

We are socially intuitive. Attigo deliver inspiring creative healthcare communications, whilst leading the way as partner of choice for socially-conscious...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics